Filters: Author is Porta, M [Clear All Filters]
Trends in citations to books on epidemiological and statistical methods in the biomedical literature. PloS one. 2013;8(5):e61837.
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. European Journal of Epidemiology. 2011;26(3):229-36.
Exploring the link between MORF4L1 and risk of breast cancer. Breast cancer research : BCR. 2011;13(2):R40.
Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutation research. 2009;682(2-3):83-93.
Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30.
Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9.
CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Digestive diseases and sciences. 2008;53(5):1417-21.
Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704.
Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer detection and prevention. 2008;32(3):267-75.
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of epidemiology and community health. 2007;61(7):641-9.
"Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? Journal of clinical epidemiology. 2007;60(12):1220-5; discussion 1226-8.
Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41.